| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448281A2 Therapeutic coating for an intravascular implant |
| 08/25/2004 | EP1448235A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448222A1 Biphasic mixtures of glp-1 and insulin |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448210A2 REGULATION OF cGMP-SPECIFIC PHOSPHODIESTERASE 9A |
| 08/25/2004 | EP1448200A2 (4-phenyl)piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/25/2004 | EP1448198A1 Nicotin-or isonicotin benzothiazole derivatives |
| 08/25/2004 | EP1448197A1 Amlodipine salt forms and processes for preparing them |
| 08/25/2004 | EP1448196A1 Benzothiazole derivatives as adenosine receptor ligands |
| 08/25/2004 | EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 08/25/2004 | EP1448194A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 08/25/2004 | EP1448193A1 Therapeutic compounds for treating dyslipidemic conditions |
| 08/25/2004 | EP1448190A2 Salts formed of an at1-receptor antagonist and a cardiovascular agent |
| 08/25/2004 | EP1448188A1 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 08/25/2004 | EP1448181A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | EP1448176A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 08/25/2004 | EP1448089A2 Devices and methods for the restoration of a spinal disc |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1448051A2 Methods and formulations for minimizing spasticity in blood vessel grafts |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1200457B1 Cysteine protease inhibitors |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1082138B1 Texaphyrin conjugates and uses thereof |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | EP0973769B1 Process for preparing eprosartan |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524081A Pyrimidine derivatives for inhibition of cell proliferation |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523986A Substituted oxazolidinones for combinational therapy |
| 08/25/2004 | CN1523985A Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523111A Secretion expressing type myocardium gene treating plasmid vector |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1523003A Novel 2-(alpha-hydroxyl amyl) and its preparing method and use |
| 08/25/2004 | CN1522757A Muscular amino acid and peptide nucleoside powder injection and its preparation method |
| 08/25/2004 | CN1522747A Drug for treating coronary heart disease or coronary disease and cardiac insufficiency, and its preparation method |
| 08/25/2004 | CN1522746A Gadol pharmaceutical preparation, method for making same and uses |
| 08/25/2004 | CN1522740A Hemiplegia hypertension and contraceptive treating plaster |
| 08/25/2004 | CN1522721A Chinese herbal medicine tea for nourishing and bringing down the blood pressure |
| 08/25/2004 | CN1522715A Use of compound red-rooted salvia drop pills in preparation of vascular permeability resistant drug |
| 08/25/2004 | CN1522714A Use of compound red-rooted salvia drop pills in preparation of mass cell degranulation prohibiting drug |
| 08/25/2004 | CN1522713A Use of compound red-rooted salvia drop pills in preparation of albumin leakage prohibiting drug |
| 08/25/2004 | CN1522705A Pharmaceutical for treating cardiovascular and cerebrovascular disease |
| 08/25/2004 | CN1522703A Yolk lecithin for injection and method for making same |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1522699A Use of prostaglandin A1 in treatment of nerve degenerative diseases such as cerebral ischemia apoplexy |
| 08/25/2004 | CN1522696A Compound preparation for lowering the blood pressure |
| 08/25/2004 | CN1522695A Indapamide slow release capsule and preparation method |
| 08/25/2004 | CN1522693A Sodium ferulic acid osmosis pump controlled release formulation and its preparation method |
| 08/25/2004 | CN1163505C Anticancer polypeptide |
| 08/25/2004 | CN1163502C Novel A1 adenosine receptor incitant |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/25/2004 | CN1163485C Amlodipine-series salt and preparing process and application thereof |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163267C Use of GLP-1 or analogs in treatment of stroke |
| 08/25/2004 | CN1163258C Medicine composite and its preparation |
| 08/25/2004 | CN1163248C Garlic health care liquid |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780887 Treating and/or preventing ischemia, pathologies associated with ischemia or pathologies associated with mitochondrial deficiencies |
| 08/24/2004 | US6780886 Administering 2,5,7,8-tetramethyl-2-( beta-carboxyethyl)-6-hydroxychromane, or 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychromane; treating arteriosclerosis, disease caused by oxidated low density lipoprotein |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/24/2004 | CA2347336C A1 adenosine receptor agonists |
| 08/24/2004 | CA2201784C Method and formulation of stimulating nitric oxide synthesis |
| 08/19/2004 | WO2004070018A2 Vegf-b and pdgf modulation of stem cells |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069820A1 Coumarin derivatives having an affinity for oestrogen receptors, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 08/19/2004 | WO2004069818A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| 08/19/2004 | WO2004069808A1 Acrylamide derivative, process for producing the same, and use |